Friday, December 09, 2016 1:41:14 PM
December 07, 2016
Focus on ChromaID to Aid in Enhanced 3-D and Holographic Imaging for Certain Medical Procedures
SEATTLE--(BUSINESS WIRE)--Dec. 7, 2016-- Visualant, Inc. (OTCQB: VSUL) – a photonics technology development company providing chromatic-based identification, authentication and diagnostic solutions, with its ChromaID™ technology, announced today that it has entered into a Joint Development Agreement with BIOMEDX Group, Inc., to develop its ChromaID technology as an exclusive analytical photonic tool for Aesthetics, Dermatology and Plastic Surgery.
The BIOMEDX Group, Inc. is a technology company founded to develop and commercialize photo-realistic 3-D and holographic digital human modeling for the medical/healthcare industry. The Company is developing specialized, interactive applications for simulation programs to capture real-time, pre-procedural modeling of facial cosmetic and reconstructive surgical methods including computer generated human anatomy to display holographic physiologically accurate simulations of the human body, including the biometrics of actual tissue and organs. Visualant and BIOMEDX will be developing applications using Visualant’s photonic ChromaID technology to analyze and determine various characteristics of the skin and underlying subdermal tissue as it relates BIOMEDX enhanced 3-D and holographic imaging for dermatologic, plastic surgery and aesthetic applications, a multi-billion dollar global market.
BIOMEDX Group, Inc. is led by Rudy Mazzocchi, an internationally renowned biomedical and technology entrepreneur. Mazzocchi is also Executive Chairman of Establishment Labs, a global aesthetic company, and Executive Chairman of LAFORGE Optical, a heads-up display eyewear company. The medical/technology team at BIOMEDX includes Dr. Raghu Raghavan, former Professor of Computer Science & Radiology at Johns Hopkins University and an author of over 150 Research Publication and 37 Patents as its Chief Technical Officer; and Goal Chopra, MD, MBA, a Neurosurgeon, Ophthalmologist and entrepreneur, who holds a faculty position in Dept. of Human Anatomical Studies at Stanford University, and a former Investment Banker at Lazard and Business Development Director of Boston Scientific Corporation, as its Chief Medical Officer.
“We are very excited to work with Visualant to jointly develop and deploy their ChromaID technology into the medical/healthcare marketplace through our existing channel relationships,” stated Mazzocchi, BIOMEDX Chairman and Acting-CEO. “We believe this Joint Development undertaking will lead to advancing the ChromaID technology not only in these addressable markets but also other large global markets for the ChromaID technology.”
“Rudy Mazzocchi and his team have a deep and proven understanding of the biomedical marketplace and the opportunities it provides for our technology,” said Visualant CEO, President and Founder, Ron Erickson. “We are very excited to work with BIOMEDX through this Joint Development Agreement, as it expands the opportunities for us to not only develop our technology but also deploy our technology in the biomedical and med-tech global markets. We intend to become a leader in utilizing photonic technology in this and other important market segments.”
http://www.businesswire.com/news/home/20161207005372/en/Visualant-BIOMEDX-Sign-Joint-Development-Agreement
Recent KNW News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/24/2024 09:00:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 09:23:58 PM
- Know Labs Study Published in IEEE Sensors Journal • Business Wire • 09/10/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 01:25:14 PM
- Know Labs, Inc. Announces $1.655 Million Public Offering • Business Wire • 08/16/2024 01:16:00 PM
- Know Labs, Inc. Reports Third Quarter FY 2024 Results • Business Wire • 08/14/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 10:01:40 AM
- Know Labs, Inc. Announces Closing of $3.445 Million Public Offering • Business Wire • 08/12/2024 10:38:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/12/2024 09:00:15 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/08/2024 04:15:14 AM
- Know Labs, Inc. Announces Pricing of $3.445 Million Public Offering • Business Wire • 08/08/2024 12:50:00 AM
- Know Labs, Inc. to Host Review of Third Quarter Fiscal Year 2024 Results on August 14, 2024 • Business Wire • 08/06/2024 01:00:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/02/2024 08:15:55 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/25/2024 01:49:42 AM
- Know Labs Publishes Clinical Results in Leading Diabetes Journal • Business Wire • 07/11/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 10:05:56 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/09/2024 08:38:26 PM
- Know Labs to Present at the American Diabetes Association’s Scientific Sessions • Business Wire • 06/21/2024 10:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/17/2024 08:52:17 PM
- Know Labs Joins the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering at Harvard University • Business Wire • 06/05/2024 01:00:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 06/03/2024 06:11:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2024 08:15:29 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM